Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates

Molly E. Gallagher, Andrew J. Sieben, Kristin N. Nelson, Alicia N.M. Kraay, Walter A. Orenstein, Ben Lopman, Andreas Handel, Katia Koelle

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)4-5
Number of pages2
JournalNature Medicine
Issue number1
StatePublished - Jan 2021
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this